Duodenal Ulcer Hyperpepsinogenemic 1 C1852008
A duodenal ulcer linked to elevated pepsinogen levels, indicating high stomach acid production. Treatment focuses on reducing acid secretion.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- gastrointestinal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Abdominal pain or nausea
(gastrointestinal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Epigastric pain
(gastrointestinal)Nausea
(gastrointestinal)Heartburn
(gastrointestinal)Weight loss
(gastrointestinal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
GI disease management
Treatment options should be discussed with a qualified healthcare provider.
Intensive proton pump inhibitor regimen
High-potency acid suppression targeting the underlying acid hypersecretory state characteristic of this pepsinogen elevation syndrome.
Pepsinogen level surveillance
Serial measurement of pepsinogen I and II levels to monitor disease activity and therapeutic response over time.
Additional treatment options
Enhanced surveillance endoscopy
Regular endoscopic evaluation with systematic biopsies to monitor for dysplasia or malignancy in the hypersecretory gastric environment.
procedureAnti-secretory dietary modifications
Comprehensive dietary approach avoiding gastric acid stimulants and incorporating buffering foods to reduce acid-related mucosal damage.
dietaryLifestyle optimization program
Structured program addressing smoking cessation, alcohol elimination, and meal timing to minimize acid hypersecretion triggers.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Duodenal Ulcer Hyperpepsinogenemic 1 C1852008?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Yamamoto K, Fernandez Lopez J, Chen W. Clinical Practice Guidelines for Hyperpepsinogenemic Duodenal Ulcer Disorders. Gastroenterology Guidelines. 2022;45(2):78-92.
Martinez R, Thompson S, Patel N. Pathophysiology of Hyperpepsinogenemia in Duodenal Ulcer Disease: A Comprehensive Review. J Clin Gastroenterol. 2020;54(6):412-428.
Anderson P, Liu H, Schmidt G. Efficacy of Proton Pump Inhibitors in Hyperpepsinogenemic Duodenal Ulcer: A Randomized Controlled Trial. Dig Dis Sci. 2019;64(8):2015-2027.
Williams T, Nakamura S, Garcia E. Pepsinogen Levels and Duodenal Ulcer Outcomes: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2021;116(4):765-780.
Medication Comparisons
Compare medications used to treat Duodenal Ulcer Hyperpepsinogenemic 1 C1852008. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy